4
Tetrahedron
more hydrophilic structure and additional points for hydrogen
9.
Bonifazi, D.; Fasano, F.; Lorenzo-Garcia, M. M.; Marinelli, D.;
Oubaha, H.; and Tasseroul, J. Boron–nitrogen doped carbon
scaffolding: organic chemistry, self-assembly and materials
applications of borazine and its derivatives. Chem. Comm., 2015,
bonding with water, 3 is likely unable to associate strongly with
the lipid bilayer thereby reducing its biological activity.
5
1(83), 15222–15236.
To confirm that the dipole moment, and not chemical stability,
was the reason for differential activity we characterized the
stability of 3 in water. Toward this end, we suspended the
compound in deionized water and heated it to 37 ⁰C for 23 h to
mimic the in vitro conditions employed in our biological assays.
The resulting mixture was then evacuated and analyzed by NMR
spectroscopy, which proved the compound to be stable in neutral
water. We recognize that there are limitations in this evaluation
as we chose deionized water over the growth media used.
However, we wanted a simple system to quantify degradation
with minimal background noise in the NMR spectroscopy
analysis and did not anticipate the additional nutrients found in
growth media to cause further degradation. Overall, we found
that the azaborine isosteric substitution is not a viable option for
improving the biological activity of our retinoid class of
antibacterial agents.
1
0. Knack, D.H.; Marshall, J.L.; Harlow, G.P.; Dudzik, A.; et al.
BN/CC isosteric compounds as enzyme inhibitors: N- and B-
ethyl-1,2-azaborine inhibit ethylbenzene hydroxylation as
nonconvertible substrate analogues. Angew Chem Int Ed Engl.
2
013, 52(9), 2599–2601.
1
1
1. Högenauer, G. and Woisetschläger, M. A diazaborine derivative
inhibits lipopolysaccharide biosynthesis. Nature, 1981, 293(5834),
6
62–664.
2. Baldock, C.; Rafferty, J. B.; Sedelnikova, S. E.; Baker, P. J.;
Stuitje, A. R.; Slabas, A. R.; Hawkes, T. R.; and Rice, D. W. A
Mechanism of Drug Action Revealed by Structural Studies of
Enoyl Reductase. Science, 1996, 274(5295), 2107–2110.
3. Baldock, C.; De Boer, G. J.; Rafferty, J. B.; Stuitje, A. R.; and
Rice, D. W. Mechanism of action of diazaborines. Biochem.
Pharma., 1998, 55(10), 1541–1549.
14. Liu, L.; Marwitz, A. J. V; Matthews, B. W.; and Liu, S. Boron
Mimetics: 1,2‐Dihydro‐1,2‐azaborines Bind inside a Nonpolar
Cavity of T4 Lysozyme. Angew Chem Int Ed Engl. 2009, 48(37),
1
6
817–6819.
1
1
1
5. Wisniewski, S.R.; Guenther, C.L; Argintaru, O.A.; and Molander,
G.A. A Convergent, Modular Approach to Functionalized 2,1-
Borazaronaphthalenes from 2-Aminostyrenes and Potassium
Organotrifluoroborates. J. Org. Chem. 2014, 79, 365−378.
6. Davies, G.H.M.; Zhou, Z.; Jouffroy, M.; and Molander, G.A.
Method for Accessing Nitrogen-Containing, B-Heteroaryl-
Substituted 2,1-Borazaronaphthalenes. J. Org. Chem., 2017, 82,
In summary, we successfully completed the synthesis of the
first azaborine isostere of a retinoid derivative. Although, the
biological activity was inferior to our lead compound we did
uncover some surprising physiochemical properties. Namely that
the naphthalene to azaborine isosteric substitution increased
water solubility, which could find promising applications to other
drug candidates. This isosteric substitution warrants further
analysis in other antimicrobial natural products to fully
understand its availability for drug discovery.
5
49−555.
7. Santos-Filho, E.F.; Sousa, J.C.; Bezerra, N.M.M.; Menezes, P.H.;
Oliveira, R.A. Environmentally friendly homocoupling reaction of
functionalized potassium aryl trifluoroborates salts in aqueous
media. Tet Lett, 2011, 52, 5288–5291.
Acknowledgments
18. Vedejs, E.; Fields, S. C.; Hayashi, R.; Hitchcock, S. R.; Powell, D.
R.; and Schrimpf, M. R. Asymmetric Memory at Labile,
Stereogenic Boron: Enolate Alkylation of Oxazaborolidinones. J.
Am. Chem. Soc. 1999, 121, 2460.
This work was funded by the National Institute of
General Medical Sciences (GM119426) and the Georgia
Research Alliance based in Atlanta, Georgia to W.M.W.
C.L.S. was supported by the National Institute of Allergy and
Infectious Diseases of the National Institutes of Health under
Award Number T32AI106699. The content is solely the
responsibility of the authors and does not necessarily
represent the official views of the National Institutes of
Health. The NMR instruments used in this work were
1
9. Aoyama, A.; Endo-Umeda, K.; Kishida, K.; Ohgane, K.; et al.
Design, Synthesis, and Biological Evaluation of Novel
Transrepression-Selective Liver X Receptor (LXR) Ligands with
5
,11- Dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-
one Skeleton. J. Med. Chem. 2012, 55, 7360−7377.
0. CLSI. M07-A9: Methods for Dilution Antimicrobial Susceptibility
Tests for Bacteria That Grow Aerobically; Approved Standard—
Ninth Edition. 1–88 (2012).
2
21. OECD (2004), Test No. 117: Partition Coefficient (n-
octanol/water), HPLC Method, OECD Guidelines for the Testing
of Chemicals, Section 1, OECD Publishing, Paris
supported
by
the
National
Science
Foundation
(CHE1531620).
2
2. Harris, M.F. and Logan, J.L. Determination of log Kow Values for
Four Drugs. J. Chem. Educ. 2014, 91, 915−918.
References
1
.
“Biggest Threats and Data.” Centers for Disease Control and
Prevention, Centers for Disease Control and Prevention, 18 Sept
Highlights: Synthesis and biological evaluation
of an antibacterial azaborine retinoid isostere
2
020, www.cdc.gov/drugresistance/biggest-threats.html.
2
3
4
.
.
.
Lewis, K. Persister cells, dormancy and infectious disease. Nat
Rev Microbiol, 2007, 5, 48–56.
Prax, M. and Bertram, R. Metabolic aspects of bacterial persisters.
Front. Cell. Infect. Microbiol., 2014, 4, 148.
Fauvart, M.; De Groote, V. N.; and Michiels, J. Role of persister
cells in chronic infections: clinical relevance and perspectives on
anti-persister therapies. Journal of Medical Microbiology, 2011,
First disclosure of an azaborine isosteric
substitution for a retinoid antibiotic.
Discovery of differences in the chemical
properties of an azaborine.
The surprising difference in antibacterial
activity between these two scaffolds.
6
0, 699–709.
5
6
.
.
Kim, W.; Zhu, W.; Hendricks, G.L.; Tyne, D.; et al., A new class
of synthetic retinoid antibiotics effective against bacterial
persisters. Nature, 2018, 556, 103-107.
Cheng, A.V.; Kim, W.; Escobar, I.E.; Mylonakis, E.; and Wuest,
W.M. Structure-activity relationship and anticancer profile of
second-generation anti-MRSA synthetic retinoids. ACS Med.
Chem. Lett. 2020, 11, 393–397.
7
8
.
.
Cheng, A.V.; Schrank, C.L.; Escobar, I.E.; Mylonakis, E.; and
Wuest, W.M. Addition of ethylamines to the phenols of bithionol
and synthetic retinoids does not elicit activity in gram-negative
bacteria. Bioorg. Med. Chem. Lett. 2020 30, 127099
Liu, Z. and Marder, T.B. B-N versus C-C: how similar are they?
Angew. Chem. Int. Ed. 2008, 47, 242–244.
Graphical Abstract